US Broker Ratings

Labcorp Holdings Inc. (LH) Stock Analysis: 19% Potential Upside and Robust Buy Ratings

Labcorp Holdings Inc. (NYSE: LH), a major player in the healthcare sector, continues to capture investor attention with its promising upside potential and strong analyst sentiment. As a leading diagnostics..

Viatris Inc. (VTRS) Stock Analysis: Navigating a Challenging Landscape with a 3.85% Dividend Yield

Viatris Inc. (NASDAQ: VTRS) stands as a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a substantial market capitalization of $14.38 billion,..

BeOne Medicines Ltd. (ONC) Stock Report: A 28.63% Upside Potential in Revolutionary Cancer Treatments

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is capturing investor attention with its substantial market capitalization of $34.42 billion and a promising 28.63% potential upside according..

BrightSpring Health Services (BTSG) Stock Analysis: A Healthcare Powerhouse with a 9.20% Potential Upside

BrightSpring Health Services, Inc. (BTSG), a significant player in the healthcare sector, specifically in the health information services industry, is capturing investor attention due to its impressive performance metrics and..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A Promising 40% Upside with Biotech Innovations

Cytokinetics, Incorporated (NASDAQ: CYTK) is making waves in the biotechnology sector with its innovative approach to treating debilitating diseases through muscle activators and inhibitors. With a market capitalization of $7.55..

argenx SE (ARGX) Stock Analysis: Exploring a 19.98% Potential Upside in the Biotech Sector

Investors seeking opportunities in the rapidly evolving biotechnology sector may want to keep an eye on argenx SE (NYSE: ARGX). This Netherlands-based biopharmaceutical company, with a market cap of $52.31..

TransMedics Group, Inc. (TMDX) Investor Outlook: Strong Buy Ratings and a Promising 17.96% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX), a pioneering player in the medical devices industry, is capturing investor attention with its innovative technologies and promising financial trajectory. Based in Andover, Massachusetts, TransMedics..

Vertex Pharmaceuticals (VRTX) Investor Outlook: Analyzing a Promising 8.8% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) remains a compelling prospect for investors eyeing the biotechnology sector. With a market capitalization of $115.92 billion, Vertex stands as a formidable player in the..

Nuvalent, Inc. (NUVL) Stock Analysis: A 40% Upside Potential with Strong Buy Ratings

Nuvalent, Inc. (NASDAQ: NUVL), a promising player in the biotechnology sector, has captured the attention of investors with its innovative approach to cancer treatment. Operating within the healthcare landscape, Nuvalent..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Uncovering a 23.60% Upside Potential in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH) is making waves in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. With a market capitalization of $4.57 billion, this..

Solventum Corporation (SOLV): Investor Outlook on 8.37% Potential Upside

Solventum Corporation (NYSE: SOLV) has captured the attention of investors with its prominent position in the healthcare sector. With a market capitalization of $13.71 billion, Solventum is a notable player..

Avantor, Inc. (AVTR) Stock Analysis: Exploring a 16.24% Potential Upside in the Healthcare Sector

Avantor, Inc. (NYSE: AVTR), a major player in the healthcare sector’s medical instruments and supplies industry, commands attention with a market capitalization of $7.81 billion. The company, headquartered in Radnor,..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Promising RAS-Targeted Therapies and a 5.37% Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) has been making waves in the biotechnology sector with its innovative approach to treating RAS-addicted cancers. As a clinical-stage precision oncology company, Revolution Medicines is..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a Challenging Market with a 23.2% Revenue Growth

Oscar Health, Inc. (NYSE: OSCR) is making waves in the healthcare sector with a robust revenue growth of 23.2%. As a healthcare technology company, Oscar Health provides innovative health plans..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating Growth and Valuation Challenges

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans sector, has been a focal point of investor interest due to its involvement in managed healthcare services for..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A 24.76% Potential Upside with Strong Buy Ratings

iRhythm Technologies, Inc. (IRTC), a leading player in the healthcare sector specializing in medical devices, is attracting significant investor attention due to its innovative cardiac monitoring solutions and promising market..

Option Care Health, Inc. (OPCH) Stock Analysis: A 13% Upside Potential Amid Robust Healthcare Growth

Option Care Health, Inc. (NASDAQ: OPCH) has positioned itself as a formidable player within the healthcare sector, specifically in the medical care facilities industry. Headquartered in Bannockburn, Illinois, the company..

STERIS plc (STE) Stock Analysis: Exploring a 12.63% Upside Potential in the Healthcare Sector

Investors looking to delve into the healthcare sector’s promising opportunities might find STERIS plc (NYSE: STE) a compelling candidate. With a market capitalization of $24.63 billion, STERIS is a significant..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Revenue Growth Shines Amid Volatile Market

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a formidable player in the Healthcare sector, specifically within the Diagnostics & Research industry. With a substantial market capitalization of $53.6 billion, the..

RadNet, Inc. (RDNT): Investor Outlook on a 29% Upside Potential in Diagnostics & Research

RadNet, Inc. (NASDAQ: RDNT), a key player in the healthcare sector, stands out with its robust potential for growth in the diagnostics and research industry. Based in the United States,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds